# Citius Pharmaceuticals, Inc.: Form 8-K, filed Apr 6, 2026

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 8-K
- Filed: 2026-04-06
- Accepted by EDGAR: Apr 6, 2026, 16:15 ET
- Period: 2026-04-06
- Accession: 0001213900-26-040474
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390026040474/ea0285222-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390026040474/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390026040474/ea0285222-8k_citius.htm

Filed Apr 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-040474. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.